Inhaled steroids and the risk of hospitalization for asthma

JAMA

Volumn 277, Issue 11, 1997, Pages 887-891

  Donahue, James G ^a,c   Weiss, Scott T ^a   Livingston, James M ^a   Goetsch, Marcia A ^a   Greineder, Dirk K ^b   Platt, Richard ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; THEOPHYLLINE;

ADOLESCENT; ADULT; AGE; AMBULATORY CARE; ARTICLE; ASTHMA; CHILD; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HOSPITALIZATION; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRESCRIPTION; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY; RISK FACTOR;

EID: 0030948376     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.11.887     Document Type: Article

References (34)

1. Halfon N, Newacheck PW. Trends in the hospitalization for acute childhood asthma, 1970-84. Am J Public Health. 1986;76:1308-1311.
2. Evans R, Mullally DI, Wilson RW, et al. National trends in the morbidity and mortality of asthma in the US. Chest. 1987;91(suppl):65S-74S.
3. Sheffer AL, Taggart VS. The National Asthma Education Program: expert panel report guidelines for the diagnosis and management of asthma. Med Care. 1993;31:MS20-MS28.
4. Barnett GO, Justice NS, Somand ME, et al. COSTAR - a computer based medical information system for ambulatory care. Proc IEEE. 1979;67: 1226-1237.
5. Rosner B. Fundamentals of Biostatistics. 3rd ed. Boston, Mass: PWS-Kent Publishing Co; 1990.
6. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons; 1989.
7. Haahtela T, Jarvinen M, Kava T, et al. Comparison of a beta2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991;325:388-392.
8. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis. 1990;142:832-836.
9. Collet JP, Boivin JF, Spitzer WO. Bias and confounding in pharmacoepidemiology. In: Strom BL, ed. Pharmacoepidemiology. 2nd ed. New York, NY: John Wiley & Sons; 1994:609-627.
10. Strunk RC. Identification of the fatality-prone subject with asthma. J Allergy Clin Immunol. 1989; 83:477-485.
11. National Asthma Education Program and National Heart, Lung, and Blood Institute. Guidelines for the Diagnosis and Management of Asthma. Washington, DC: US Dept of Health and Human Services; 1991. Publication 91-3042.
12. Gottlieb DJ, Beiser AS, O'Connor GT. Poverty, race, and medication use are correlates of asthma hospitalization rates. Chest. 1995;108:28-35.
13. Wennergren G, Kristjasson S, Strannegard I. Decrease in hospitalization for treatment of childhood asthma with increased use of antiinflammatory treatment, despite an increase in the prevalence of asthma. J Allergy Clin Immunol. 1996;97: 742-748.
14. Dales RE, Schweitzer I, Kerr P, Gougeon L, Rivington R, Draper J. Risk factors for recurrent emergency department visits for asthma. Thorax. 1995;50:520-524.
15. Barnes PJ. A new approach to the treatment of asthma. N Engl J Med. 1989;321:1517-1527.
16. Kerstjens HAM, Brand PLP, Hughes MD, et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med. 1992;327:1413-1419.
17. Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis. 1991;143:1317-1321.
18. Toogood JH, Jennings BH, Baskerville JC, Lefcoe NM. Aerosol corticosteroids. In: Weiss EB, Stein M, eds. Bronchial Asthma: Mechanisms and Therapeutics. 3rd ed. Boston, Mass: Little Brown & Co; 1993:818-841.
19. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. Am Rev Respir Dis. 1992;146:547-554.
20. Kerrebijn KF. Use of topical corticosteroids in the treatment of childhood asthma. Am Rev Respir Dis. 1990;141:S77-S81.
21. Reed CE. Aerosol glucocorticoid treatment of asthma. Am Rev Respir Dis. 1990;141:S82-S88.
22. Toogood JH. Complications of topical steroid therapy for asthma. Am Rev Respir Dis. 1990;141: S89-S96.
23. Clark TJH. Inhaled corticosteroid therapy: a substitute for theophylline as well as prednisone? J Allergy Clin Immunol. 1985;76:330.
24. Barnes PJ. Effects of glucocorticosteroids on airway hyperresponsiveness. Am Rev Respir Dis. 1990;141:S70-S76.
25. Benatar S. Fatal asthma. N Engl J Med. 1986; 314:423-428.
26. Speizer FE, Doll R, Heaf P. Observations on recent increase in mortality from asthma. BMJ. 1968;1:335-339.
27. Conolly ME, Davies DS, Dollery CT, George CF. Resistance to beta adrenoceptor stimulants (a possible explanation for the rise in asthma deaths). Br J Pharmacol. 1971;43:389-402.
28. McFadden ER. Perspectives in beta-agonist therapy: vox clamantis in deserto vel lux in tenebris? J Allergy Clin Immunol. 1995;95:641-651.
29. Barrett TE, Strom BL. Inhaled beta-adrenergic receptor agonists in asthma: more harm than good? Am J Respir Crit Care Med. 1995;151:574-577.
30. Suissa S, Blais L, Ernst P. Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma. Eur Respir J. 1994;7:1602-1609.
31. Donahue JG, Weiss ST, Goetsch MA, Livingston JM, Greineder DK, Platt R. Assessment of asthma using automated and full text medical records. J Asthma. In press.
32. O'Brien-Ladner A. Asthma: new insights in the management of older adults. Geriatrics. 1994;49: 20-25,30-32.
33. Skorodin MS. Pharmacotherapy for asthma and chronic obstructive pulmonary disease. Arch Intern Med. 1993;153:814-828.
34. Weiss KB, Gergen PJ, Crain EF. Inner-city asthma: the epidemiology of an emerging US public health concern. Chest. 1992;101:362S-367S.